Colgate-Palmolive Company $CL Shares Sold by Generali Asset Management SPA SGR

Generali Asset Management SPA SGR reduced its stake in shares of Colgate-Palmolive Company (NYSE:CL) by 25.5% during the 3rd quarter, Holdings Channel.com reports. The fund owned 75,835 shares of the company’s stock after selling 25,971 shares during the quarter. Generali Asset Management SPA SGR’s holdings in Colgate-Palmolive were worth $6,062,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently bought and sold shares of CL. Golden State Equity Partners increased its position in shares of Colgate-Palmolive by 15.4% during the third quarter. Golden State Equity Partners now owns 3,263 shares of the company’s stock worth $261,000 after purchasing an additional 436 shares in the last quarter. Mattern Capital Management LLC boosted its position in shares of Colgate-Palmolive by 1.5% in the 3rd quarter. Mattern Capital Management LLC now owns 98,184 shares of the company’s stock valued at $7,849,000 after purchasing an additional 1,483 shares during the period. Financial Consulate Inc. purchased a new position in Colgate-Palmolive during the 3rd quarter worth approximately $68,000. Salomon & Ludwin LLC grew its stake in Colgate-Palmolive by 3.4% during the 3rd quarter. Salomon & Ludwin LLC now owns 10,093 shares of the company’s stock worth $787,000 after buying an additional 330 shares during the last quarter. Finally, Mather Group LLC. increased its position in Colgate-Palmolive by 7.6% during the third quarter. Mather Group LLC. now owns 7,617 shares of the company’s stock worth $609,000 after buying an additional 536 shares during the period. 80.41% of the stock is owned by hedge funds and other institutional investors.

Colgate-Palmolive Stock Performance

Shares of CL opened at $77.66 on Friday. The stock has a market capitalization of $62.60 billion, a P/E ratio of 21.75, a P/E/G ratio of 5.35 and a beta of 0.30. The company has a debt-to-equity ratio of 5.90, a quick ratio of 0.60 and a current ratio of 0.93. Colgate-Palmolive Company has a 1 year low of $74.54 and a 1 year high of $100.18. The company’s fifty day moving average is $78.53 and its two-hundred day moving average is $82.32.

Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, October 31st. The company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.89 by $0.02. Colgate-Palmolive had a net margin of 14.47% and a return on equity of 333.39%. The business had revenue of $5.13 billion for the quarter, compared to the consensus estimate of $5.17 billion. During the same quarter in the previous year, the firm earned $0.91 earnings per share. The business’s quarterly revenue was up 1.9% compared to the same quarter last year. On average, sell-side analysts predict that Colgate-Palmolive Company will post 3.75 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Shareholders of record on Wednesday, January 21st will be issued a $0.52 dividend. This represents a $2.08 dividend on an annualized basis and a yield of 2.7%. The ex-dividend date of this dividend is Wednesday, January 21st. Colgate-Palmolive’s payout ratio is currently 58.26%.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on CL shares. Weiss Ratings reissued a “hold (c)” rating on shares of Colgate-Palmolive in a report on Wednesday, October 8th. Evercore ISI reduced their price target on shares of Colgate-Palmolive from $100.00 to $94.00 and set an “outperform” rating for the company in a research report on Monday, November 3rd. Bank of America decreased their price target on shares of Colgate-Palmolive from $98.00 to $88.00 and set a “buy” rating for the company in a research note on Wednesday, October 8th. Citigroup dropped their price objective on shares of Colgate-Palmolive from $105.00 to $95.00 and set a “buy” rating on the stock in a research note on Monday, November 3rd. Finally, Jefferies Financial Group set a $85.00 target price on shares of Colgate-Palmolive in a report on Tuesday, December 16th. Ten equities research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, Colgate-Palmolive presently has a consensus rating of “Moderate Buy” and an average target price of $88.81.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.